LBP and metabolic disease: Further data supporting a potential protective role of LBP in metabolic diseases come from experimental rodent models, where liver LBP gene downregulation resulted in a significant increase in the hepatic expression of markers of inflammatory liver injury, regardless of LPS levels [22].